CVS HEALTH CORPORATION

(CVS)
  Report
Delayed Nyse  -  05/27 04:00:02 pm EDT
98.05 USD   +0.26%
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare...
05/27Bernstein Downgrades CVS Health to Market Perform From Outperform; Price Target is $112
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health, Uber to Provide Free Transportation Under New Health Zones Initiative

01/19/2022 | 09:18am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 0.26% 98.05 Delayed Quote.-4.95%
UBER TECHNOLOGIES, INC. 2.47% 23.67 Delayed Quote.-43.55%
All news about CVS HEALTH CORPORATION
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
05/27Bernstein Downgrades CVS Health to Market Perform From Outperform; Price Target is $112
MT
05/25REPORT : CVS ends filling prescriptions connected with Cerebral, Done Health
AQ
05/25TIMELINE : Baby formula crunch in U.S. forces scramble to boost supplies
RE
05/20GLOBAL ACCESSIBILITY AWARENESS DAY : What accessibility means to CVS Health
PU
05/20OmniLife Named Winner of the 2022 Lyfebulb-CVS Kidney Care® Innovation Challenge
PR
05/20Baby formula crunch in U.S. forces scramble to boost supplies
RE
05/19Aetna Donates $225,000 to Iowa Community Health Partners
PR
05/16CVS HEALTH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2022 309 B - -
Net income 2022 9 359 M - -
Net Debt 2022 38 781 M - -
P/E ratio 2022 14,0x
Yield 2022 2,18%
Capitalization 129 B 129 B -
EV / Sales 2022 0,54x
EV / Sales 2023 0,51x
Nbr of Employees 258 000
Free-Float 74,5%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 98,05 $
Average target price 117,77 $
Spread / Average Target 20,1%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
Roger N. Farah Chairman
Sreekanth Chaguturu Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President